Latest Healthcare Research Reports

Tag: biologics testing market opportunities

  • Global Biologics Testing Market Revenue Expected To Reach $15.07 Billion By 2030

    Global Biologics Testing Market Revenue Expected To Reach $15.07 Billion By 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Will The Market Size Of The Biologics Testing Market Progress Through 2030?

    The biologics testing market has experienced significant expansion recently. Projections indicate a rise from $6.83 billion in 2025 to $7.99 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.0%. Historically, this growth was driven by factors such as increased manufacturing volumes for biologics, an uptick in vaccine development initiatives, stricter regulatory demands for product safety, the broader acceptance of monoclonal antibody treatments, and the proliferation of contract testing laboratories.

    The biologics testing market is projected to expand quickly over the coming years, anticipated to reach a valuation of $15.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. This growth can be attributed to several factors including the escalating demand for rapid release testing, a surge in the adoption of automated quality control systems, the broadening requirements for cell and gene therapy testing, an intensifying focus on data integrity, and increased investments in digital laboratory infrastructure. Furthermore, major developments within this period are expected to include the greater adoption of advanced analytical testing platforms, an increased call for comprehensive biologics quality testing, the expanding application of high-sensitivity assays, the widening scope of outsourced testing services, and a heightened emphasis on regulatory compliance testing.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

    What Are The Main Drivers Accelerating The Growth Of The Biologics Testing Market?

    The expansion of the pharmaceutical and biotechnology sectors is projected to drive the biologics testing market forward. The pharmaceutical industry concentrates on creating and producing medicines for diverse ailments and health conditions. Meanwhile, the biotechnology industry applies technology to biological processes and healthcare. Biologics testing encompasses examinations to detect and measure impurities, evaluate stability, and gauge the immune reaction to a medication. The expansion of these industries has also spurred progress in biologics testing technology, including the creation of novel analytical instruments and methods. This has enabled more precise and effective testing, thereby shortening the development timeline and costs associated with introducing new biologics. For example, in July 2024, as per Eurostat, a Belgium-based governing body, pharmaceutical production in the EU escalated to €44 billion ($46.7 billion) in 2023, indicating substantial growth within the sector. Consequently, the burgeoning pharmaceutical and biotechnology industries are propelling the biologics testing market’s expansion.

    Which Segment Groups Define The Biologics Testing Market Landscape?

    The biologics testing market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Other Products

    2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

    3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

    Subsegments:

    1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents

    2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers

    3) By Other Products: Software, Consumables, Reference Standards

    What Trends Are Affecting The Growth Of The Biologics Testing Market?

    Major companies operating in the biological testing market are actively pursuing innovative technologies, such as protein engineering techniques, to enhance their market profitability. Protein engineering is defined as the process of designing and modifying proteins to create new or improved variants possessing desired characteristics. A notable illustration is the Queensland University of Technology, an Australia-based university, which in July 2023, unveiled a novel protein-engineering technique enabling the quick and precise creation of new diagnostic tests. This advancement offers a new approach for improving and broadening laboratory testing capabilities, promising substantial positive effects on both public health and economic sectors.

    Which Industry Players Are Present In The Biologics Testing Market?

    Major companies operating in the biologics testing market are Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, QIAGEN N.V., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG

    Access The Complete Biologics Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Which Region Is The Primary Market For The Biologics Testing Market?

    North America was the largest region in the biologics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Biologics Testing Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

    Browse Through More Reports Similar to the Global Biologics Testing Market 2026, By The Business Research Company

    Biologics Contract Development Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

    Veterinary Biologics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

    Biologics Cdmo Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Corporate wellness market outlook (2026–2030) with key drivers

    Corporate wellness market outlook (2026–2030) with key drivers

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    “What Is The Estimated Market Size Of The Corporate Wellness Market In 2026, And How Will Its Value Evolve By 2030?

    The corporate wellness market has demonstrated robust growth in recent years. It is projected to expand from $74.89 billion in 2025 to $81.55 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.9%. This historical growth can be attributed to several factors including increasing workplace stress levels, rising healthcare costs for employers, concerns about absenteeism, the early adoption of wellness initiatives, and the necessity for productivity optimization.

    The corporate wellness market is anticipated to experience substantial growth in the upcoming years, projected to reach $115.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This expansion during the forecast period is primarily driven by factors such as the broadening of remote workforces, heightened mental health awareness, the development of digital wellness platforms, a stronger emphasis from employers on employee retention, and increased regulatory assistance. Significant trends expected in this period encompass an intensifying focus on employee mental health, the extension of preventive wellness initiatives, a greater embrace of hybrid wellness models, increased application of data-driven wellness insights, and the integration of lifestyle management services.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/corporate-wellness-global-market-report

    Which Key Factors Are Driving The Corporate Wellness Market Growth?

    The escalating occurrence of chronic illnesses among corporate employees is projected to fuel the expansion of the corporate wellness market in the foreseeable future. A chronic illness is characterized as a medical ailment or condition that typically persists for three months or more and has the potential to worsen over time. This increase in chronic conditions among corporate personnel expands the corporate wellness market as company wellness initiatives improve worker health by offering a diverse array of services aimed at reducing chronic disease conditions. For instance, in February 2024, data from the Centers for Disease Control, a US-based federal agency, indicated that an increasing number of Americans are grappling with multiple chronic conditions, with 42% experiencing two or more and 12% having at least five. This accounts for nearly 90% of the annual $4.1 trillion healthcare expenditure allocated to managing chronic diseases and mental health conditions. Consequently, the rising prevalence of chronic illnesses among corporate workers is a key factor propelling the growth of the corporate wellness market.

    How Is The Corporate Wellness Market Categorized Across Its Segment Groups?

    The corporate wellness market covered in this report is segmented –

    1) By Service: Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition And Weight Management, Stress Management, Other Services

    2) By Delivery Model: Onsite, Offsite

    3) By Category: Fitness And Nutrition Consultants, Psychological Therapists, Organizations Or Employers

    4) By End User: Private Sector, Public Sector, Other End Users

    Subsegments:

    1) By Health Risk Assessment: Online Assessments, In-Person Assessments

    2) By Fitness: On-Site Fitness Classes, Fitness Challenges, Personal Training

    3) By Smoking Cessation: Counseling Programs, Support Groups, Pharmacotherapy

    4) By Health Screening: Biometrics Screening, Preventive Health Screenings

    5) By Nutrition And Weight Management: Nutritional Counseling, Weight Loss Programs

    6) By Stress Management: Stress Reduction Workshops, Mindfulness Training, Counseling Services

    7) By Other Services: Employee Assistance Programs (EAP), Wellness Incentives, Health Education Programs

    Which Trends Are Guiding The Direction Of The Corporate Wellness Market?

    Leading companies in the corporate wellness market are intensifying their efforts to create innovative programs, such as advanced preventative care initiatives. An advanced preventative care program signifies a comprehensive and sophisticated healthcare strategy that integrates cutting-edge medical technologies. For example, in November 2023, WELL Health Technologies Corp., a Canada-based digital health company, announced the introduction of its ‘WELL Longevity+ Program’. This program is specifically designed to enhance preventative health, serving as a progressive expansion of its preventative health division. The ‘WELL Longevity+ Program’ integrates AI technologies and precision diagnostic testing, allowing for the early diagnosis and identification of various health conditions, including heart disease, cancer, and neurodegenerative diseases.

    Which Firms Are Influencing Competition In The Corporate Wellness Market?

    Major companies operating in the corporate wellness market are ComPsych Corporation, Wellness Corporate Solutions LLC, Virgin Pulse Inc., Provant Health Solutions LLC, Exos, Marino Wellness, Privia Health Group Inc., Vitality Group International Inc., Wellsource Inc., Central Corporate Wellness, SOL Wellness LLC, Well Nation, Aduro Inc., Beacon Health Options Inc., Fitbit Inc., Bupa Wellness Pty Ltd., Truworth Health Technologies Pvt. Ltd., Sodexo Group, Quest Diagnostics Incorporated, 1to1help.net Pvt. Ltd., CHC Wellbeing lnc., Wellness 360 Technologies Inc., Premise Health, Kinema Fitness lnc., Health Advocate Inc., Onlife Health, TotalWellness Health, HealthCheck360, RedBrick Health, Corporate Fitness Works Inc.

    Get The Full Corporate Wellness Market Report:

    https://www.thebusinessresearchcompany.com/report/corporate-wellness-global-market-report

    Which Region Represents The Largest Share Of The Corporate Wellness Market?

    North America was the largest region in the corporate wellness market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global corporate wellness market during the forecast period. The regions covered in the corporate wellness market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Corporate Wellness Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/corporate-wellness-global-market-report

    Browse Through More Reports Similar to the Global Corporate Wellness Market 2026, By The Business Research Company

    Mental Wellness Market Report 2026

    https://www.thebusinessresearchcompany.com/report/mental-wellness-global-market-report

    Corporate Wellness Solutions Market Report 2026

    https://www.thebusinessresearchcompany.com/report/corporate-wellness-solutions-global-market-report

    Health And Wellness Market Report 2026

    https://www.thebusinessresearchcompany.com/report/health-and-wellness-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model”

  • Global Biologics Testing Market to Hit $15.07B by 2030 at 17.2% CAGR

    Global Biologics Testing Market to Hit $15.07B by 2030 at 17.2% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Biologics Testing Market Between 2026 And 2030?

    The biologics testing market has seen rapid expansion in recent years. Its valuation is forecast to climb from $6.83 billion in 2025 to $7.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.0%. This market’s historical growth can be attributed to several factors, including increasing biologics manufacturing volumes, the expansion of vaccine development programs, rising regulatory expectations for product safety, wider adoption of monoclonal antibody therapies, and the growth of contract testing laboratories.

    The biologics testing market is projected to experience substantial growth in the coming years. This market is anticipated to reach $15.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. Several factors contribute to this projected expansion, including a heightened demand for rapid release testing, the increasing implementation of automated quality control systems, the broadening requirements for cell and gene therapy testing, an intensifying emphasis on data integrity, and increased capital expenditure in digital laboratory infrastructure. Key trends observed during this period involve the wider acceptance of advanced analytical testing platforms, a growing need for thorough biologics quality testing, the expanded application of high-sensitivity assays, the proliferation of outsourced testing services, and a strengthened commitment to regulatory compliance testing.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Which Strong Drivers Are Impacting The Biologics Testing Market Growth?

    The escalating pharmaceutical and biotechnology sectors are anticipated to fuel the expansion of the biologics testing market in the future. The pharmaceutical industry’s main objective is the creation and production of drugs for diverse ailments and health states. In contrast, the biotechnology industry dedicates its efforts to leveraging technology in biology and medical care. Biologics testing encompasses examinations for the identification and measurement of contaminants, stability evaluation, and the assessment of a drug’s immune system reaction. The expansion of the pharmaceutical and biotechnology industries has likewise prompted progress in biologics testing technology, exemplified by the introduction of novel analytical instruments and methodologies. Such developments have facilitated more precise and streamlined testing, thereby lowering the duration and expense involved in launching new biologics. As an illustration, data released in July 2024 by Eurostat, a Belgium-based governing body, showed that pharmaceutical output in the EU climbed to €44 billion ($46.7 billion) in 2023, demonstrating substantial growth within the sector. Consequently, the fast-expanding pharmaceutical and biotechnology industries are indeed propelling the growth of the biologics testing market.

    How Is The Biologics Testing Market Categorized Across Its Segment Groups?

    The biologics testing market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Other Products

    2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

    3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

    Subsegments:

    1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents

    2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers

    3) By Other Products: Software, Consumables, Reference Standards

    Which Trends Are Contributing To Changes In The Biologics Testing Market?

    Leading businesses within the biological testing market are developing novel technologies, including protein engineering methods, to enhance their market profitability. Protein engineering involves the systematic design and alteration of proteins to produce novel or enhanced versions possessing specific characteristics. As an example, during July 2023, the Queensland University of Technology, an Australia-based academic institution, introduced an innovative protein-engineering approach that enables the rapid and precise development of new diagnostic tests. This technology provides a new avenue for improving and broadening laboratory testing capabilities, promising substantial beneficial effects on public health and economic growth.

    Which Firms Are Influencing Competition In The Biologics Testing Market?

    Major companies operating in the biologics testing market are Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, QIAGEN N.V., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG

    Get The Full Biologics Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Which Geographic Region Dominates The Biologics Testing Market?

    North America was the largest region in the biologics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Biologics Testing Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Browse Through More Reports Similar to the Global Biologics Testing Market 2026, By The Business Research Company

    Biologics Cdmo Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

    Biologics Contract Development Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

    Veterinary Biologics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Biologics Testing Market to Hit $15.07B by 2030 at 17.2% CAGR

    Global Biologics Testing Market to Hit $15.07B by 2030 at 17.2% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Biologics Testing Market Between 2026 And 2030?

    The biologics testing market has seen rapid expansion in recent years. Its valuation is forecast to climb from $6.83 billion in 2025 to $7.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.0%. This market’s historical growth can be attributed to several factors, including increasing biologics manufacturing volumes, the expansion of vaccine development programs, rising regulatory expectations for product safety, wider adoption of monoclonal antibody therapies, and the growth of contract testing laboratories.

    The biologics testing market is projected to experience substantial growth in the coming years. This market is anticipated to reach $15.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. Several factors contribute to this projected expansion, including a heightened demand for rapid release testing, the increasing implementation of automated quality control systems, the broadening requirements for cell and gene therapy testing, an intensifying emphasis on data integrity, and increased capital expenditure in digital laboratory infrastructure. Key trends observed during this period involve the wider acceptance of advanced analytical testing platforms, a growing need for thorough biologics quality testing, the expanded application of high-sensitivity assays, the proliferation of outsourced testing services, and a strengthened commitment to regulatory compliance testing.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Which Strong Drivers Are Impacting The Biologics Testing Market Growth?

    The escalating pharmaceutical and biotechnology sectors are anticipated to fuel the expansion of the biologics testing market in the future. The pharmaceutical industry’s main objective is the creation and production of drugs for diverse ailments and health states. In contrast, the biotechnology industry dedicates its efforts to leveraging technology in biology and medical care. Biologics testing encompasses examinations for the identification and measurement of contaminants, stability evaluation, and the assessment of a drug’s immune system reaction. The expansion of the pharmaceutical and biotechnology industries has likewise prompted progress in biologics testing technology, exemplified by the introduction of novel analytical instruments and methodologies. Such developments have facilitated more precise and streamlined testing, thereby lowering the duration and expense involved in launching new biologics. As an illustration, data released in July 2024 by Eurostat, a Belgium-based governing body, showed that pharmaceutical output in the EU climbed to €44 billion ($46.7 billion) in 2023, demonstrating substantial growth within the sector. Consequently, the fast-expanding pharmaceutical and biotechnology industries are indeed propelling the growth of the biologics testing market.

    How Is The Biologics Testing Market Categorized Across Its Segment Groups?

    The biologics testing market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Other Products

    2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

    3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

    Subsegments:

    1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents

    2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers

    3) By Other Products: Software, Consumables, Reference Standards

    Which Trends Are Contributing To Changes In The Biologics Testing Market?

    Leading businesses within the biological testing market are developing novel technologies, including protein engineering methods, to enhance their market profitability. Protein engineering involves the systematic design and alteration of proteins to produce novel or enhanced versions possessing specific characteristics. As an example, during July 2023, the Queensland University of Technology, an Australia-based academic institution, introduced an innovative protein-engineering approach that enables the rapid and precise development of new diagnostic tests. This technology provides a new avenue for improving and broadening laboratory testing capabilities, promising substantial beneficial effects on public health and economic growth.

    Which Firms Are Influencing Competition In The Biologics Testing Market?

    Major companies operating in the biologics testing market are Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, QIAGEN N.V., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG

    Get The Full Biologics Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Which Geographic Region Dominates The Biologics Testing Market?

    North America was the largest region in the biologics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Biologics Testing Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Browse Through More Reports Similar to the Global Biologics Testing Market 2026, By The Business Research Company

    Biologics Cdmo Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

    Biologics Contract Development Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

    Veterinary Biologics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biologics Testing Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

    Biologics Testing Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Increase Is Anticipated For The Biologics Testing Market Over The 2026–2030 Period?

    The biologics testing market has experienced significant growth in recent years. Its value is projected to expand from $6.83 billion in 2025 to $7.99 billion in 2026, reflecting a compound annual growth rate (CAGR) of 17.0%. Historically, this growth has been driven by increased biologics manufacturing volumes, the expansion of vaccine development programs, heightened regulatory expectations regarding product safety, broader adoption of monoclonal antibody therapies, and the proliferation of contract testing laboratories.

    The biologics testing market size is anticipated to undergo significant growth in the coming years. It is projected to expand to $15.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. This expansion during the forecast period is driven by a heightened demand for rapid release testing, the increasing integration of automated quality control systems, the broadening scope of cell and gene therapy testing requirements, a stronger emphasis on data integrity, and increasing investments in digital laboratory infrastructure. Prominent trends observed during the forecast period encompass the wider adoption of advanced analytical testing platforms, a surging requirement for comprehensive biologics quality testing, the expanding utilization of high-sensitivity assays, the proliferation of outsourced testing services, and an intensified focus on regulatory compliance testing.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

    Which Economic Or Industry Drivers Are Impacting The Biologics Testing Market?

    The expanding pharmaceutical and biotechnology sectors are projected to fuel the advancement of the biologics testing market in the future. The pharmaceutical industry primarily concentrates on creating and producing medicines for diverse ailments and health issues. Conversely, the biotechnology industry centers on applying technology to biological sciences and healthcare. Biologics testing encompasses examinations to pinpoint and measure impurities, determine stability, and gauge the immune reaction to a therapeutic agent. The expansion of these industries has also spurred progress in biologics testing technology, for instance, through the creation of novel analytical instruments and methods. This development has enabled more precise and streamlined testing, thereby lowering the duration and expense involved in launching new biologics. For example, data from July 2024, provided by Eurostat, a governing organization situated in Belgium, indicated that pharmaceutical output in the EU reached €44 billion ($46.7 billion) in 2023, signifying substantial expansion within the industry. Consequently, the swift expansion of the pharmaceutical and biotechnology industries is a key factor propelling the biologics testing market forward.

    How Is The Biologics Testing Market Segmented Across Key Categories?

    The biologics testing market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Other Products

    2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

    3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

    Subsegments:

    1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents

    2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers

    3) By Other Products: Software, Consumables, Reference Standards

    What Key Trends Are Influencing The Development Of The Biologics Testing Market?

    Key companies operating within the biological testing market are introducing novel technologies, such as protein engineering techniques, to elevate their profitability. Protein engineering pertains to the intentional design and modification of proteins to yield new or enhanced variants possessing desired attributes. For instance, in July 2023, Queensland University of Technology, an Australia-based university, unveiled an innovative protein-engineering method that facilitates the rapid and precise creation of new diagnostic tests. This technology presents a fresh approach for refining and broadening laboratory testing capabilities, promising a substantial positive influence on both public health and the economy.

    Who Are The Dominant Players Shaping The Biologics Testing Market Landscape?

    Major companies operating in the biologics testing market are Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, QIAGEN N.V., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG

    Read the full biologics testing market report here:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    What Are The Top-Performing Regions Within The Biologics Testing Market?

    North America was the largest region in the biologics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Biologics Testing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

    Browse Through More Reports Similar to the Global Biologics Testing Market 2026, By The Business Research Company

    Biologics Contract Development Global Market Report

    https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

    Veterinary Biologics Global Market Report

    https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

    Biologics Cdmo Global Market Report

    https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biologics Testing Industry Growth Insights: Revenue Forecast to 2030

    Biologics Testing Industry Growth Insights: Revenue Forecast to 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the biologics testing market from 2026–2035 with trusted insights from The Business Research Company

    What long-term size projections exist for the Biologics Testing Market covering 2026–2035?

    The size of the biologics testing market has experienced significant expansion over recent years. It is anticipated to expand from $6.83 billion in 2025 to $7.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.0%. Factors contributing to its historical growth include an increase in biologics manufacturing volumes, the expansion of vaccine development programs, heightened regulatory expectations regarding product safety, broader adoption of monoclonal antibody therapies, and the rise of contract testing laboratories.

    The biologics testing market is projected to experience substantial expansion in the coming years. This market is forecast to reach $15.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. This anticipated growth is primarily driven by factors such as a surge in demand for rapid release testing, the increasing implementation of automated quality control systems, the expanding requirements for cell and gene therapy testing, an amplified emphasis on data integrity, and greater investments in digital laboratory infrastructure. Key trends observed within this timeframe encompass the increasing utilization of advanced analytical testing platforms, a heightened demand for thorough biologics quality testing, the expanding application of high-sensitivity assays, the proliferation of outsourced testing services, and a strengthened focus on testing for regulatory compliance.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

    Which Drivers Are Impacting The Competitive Landscape Of The Biologics Testing Market?

    The biologics testing market is anticipated to expand due to the swift expansion of the pharmaceutical and biotechnology sectors. The pharmaceutical industry primarily concentrates on creating and producing medicines for diverse ailments and health issues. Conversely, the biotechnology industry centers on applying technology to biological sciences and healthcare. Biologics testing encompasses evaluations to detect and measure impurities, determine stability, and gauge the immune reaction to a drug. The expansion of these industries has also spurred progress in biologics testing technology, such as the creation of novel analytical instruments and methods. This progress has facilitated more precise and effective testing, thereby cutting down the duration and expense of introducing new biologics to the market. For example, in July 2024, Eurostat, a governing body located in Belgium, reported that pharmaceutical output in the EU surged to €44 billion ($46.7 billion) in 2023, indicating substantial growth in the field. Consequently, the rapid development of the pharmaceutical and biotechnology industries is fueling the growth of the biologics testing market.

    What Segments Are Identified Within The Structure Of The Biologics Testing Market?

    The biologics testing market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Other Products

    2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

    3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

    Subsegments:

    1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents

    2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers

    3) By Other Products: Software, Consumables, Reference Standards

    Which Trends Are Expected To Influence The Biologics Testing Market In The Upcoming Years?

    Leading companies in the biological testing market are developing novel technologies, such as protein engineering techniques, to enhance their market profitability. Protein engineering involves the design and modification of proteins to generate new or improved versions with specific desired attributes. For example, in July 2023, Queensland University of Technology, an Australia-based university, introduced an innovative protein-engineering technique enabling the swift and precise creation of new diagnostic tests. This technology provides a fresh approach for improving and expanding laboratory testing, which is expected to have a notable positive influence on both health and the economy.

    Which Key Market Players Are Investing In Expansion And Innovation Within The Biologics Testing Market?

    Major companies operating in the biologics testing market are Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, QIAGEN N.V., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Which Regions Are Poised For Strategic Growth In The Biologics Testing Market?

    North America was the largest region in the biologics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Biologics Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

    Browse Through More Reports Similar to the Global Biologics Testing Market 2026, By The Business Research Company

    Biologics Cdmo Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

    Biologics Contract Development Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

    Veterinary Biologics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biologics Testing Market Forecast 2025–2034: Where Businesses Should Invest Next

    Biologics Testing Market Forecast 2025–2034: Where Businesses Should Invest Next

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    #What Is The Projected Market Size Of The Biologics Testing Market By 2029?

    The size of the biologics testing market has seen rapid expansion in recent years. This market is projected to increase from $5.92 billion in 2024 to $6.83 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 15.4%. Historically, this growth was influenced by an increase in biologics development, stringent regulatory standards, a focus on quality control in bioprocessing, a rise in biopharmaceutical investments, and the expansion of biomanufacturing capacity.

    The biologics testing market is anticipated to experience substantial growth in the coming years. It is projected to achieve a value of $12.84 billion by 2029, with a compound annual growth rate (CAGR) of 17.1%. This expansion during the forecast period is primarily driven by the emergence of advanced therapies, a heightened demand for contract testing services, the expansion of biologics pipelines, the globalization of biopharmaceutical manufacturing, and the increasing need for rapid testing solutions. Noteworthy trends for the forecast period involve advanced analytical technologies, cell-based assays, next-generation sequencing (NGS), the adoption of quality by design (QBD) principles, the integration of artificial intelligence (AI), and efficient methods for product release.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

    What Are The Main Drivers Boosting The Biologics Testing Industry’s Expansion?

    The expansion of the pharmaceutical and biotechnology sectors is projected to drive the biologics testing market’s development. The pharmaceutical industry predominantly concentrates on the creation and production of medicines for various health issues, while the biotechnology industry centers on leveraging technology in biological and medical fields. Biologics testing encompasses examinations to pinpoint and measure impurities, gauge stability, and assess a drug’s immune reaction. This growth in the pharmaceutical and biotechnology industries has also fostered improvements in biologics testing technology, such as the introduction of novel analytical instruments and methods. These advancements have enabled more precise and effective testing, thereby decreasing the duration and expense associated with launching new biologics. For example, in July 2024, Eurostat, a Belgium-based governing body, reported that pharmaceutical production in the EU rose from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, indicating substantial sector expansion. Consequently, the burgeoning pharmaceutical and biotechnology industries are propelling the growth of the biologics testing market.

    Which Key Segments Fueling The Biologics Testing Market?

    The biologics testingmarket covered in this report is segmented –

    1) By Product: Reagents And Kits; Instruments; Other Products

    2) By Test Type: Endotoxin Test; Sterility Test; Mycoplasma Tests; Bioburden Tests; Residual Host-Cell Proteins And DNA Detection Tests; Virus Safety Test; Other Test Types

    3) By Application: Vaccine Development And Manufacturing; Monoclonal Antibodies Development And Manufacturing; Cellular And Gene Therapy Products Development And Manufacturing; Blood And Blood Products Development And Manufacturing; Other Applications

    Subsegments:

    1) By Reagents And Kits: ELISA Kits; PCR Kits; Cell Culture Reagents; Other Assay Kits

    2) By Instruments: Spectrophotometers; Chromatography Systems; Microplate Readers; Other Analytical Instruments

    3) By Other Products: Software; Consumables; Reference Standards

    What Trends Are Redefining The Biologics Testing Market Dynamics?

    Product innovations are becoming a significant trend in the biologics testing market. Companies within this market are implementing new, innovative products to uphold their market standing. For instance, in December 2022, Charles River Laboratories International, Inc., a US-based non-clinical contract research organization, unveiled the Endosafe Nexus 200, expanding its extensive endotoxin testing portfolio. The Nexus 200 is a fully robotic instrument, compliant with data integrity standards, marking a further advancement for Charles River. It incorporates Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and can handle simple or complex serial dilutions for testing water, in-process materials, and final products. Running on Endosafe EndoScan-V version 6.1, the system facilitates data export to a Laboratory Information Management System (LIMS) interface and delivers enhanced traceability, security, and data management via an integrated touch screen.

    Which Leading Companies Dominate The Biologics Testing Market Share?

    Major companies operating in the biologics testing market include Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Celgene Corporation, Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Gilead Sciences Inc., Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, Johnson & Johnson Inc., QIAGEN N.V., GlaxoSmithKline plc, Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG, Novartis AG, Eli Lilly and Company, Pfizer Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    What Regional Growth Trends Are Shaping The Biologics Testing Market Outlook?

    North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request A Customized Version Of The Biologics Testing Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

    Browse Through More Reports Similar to the Global Biologics Testing Market 2025, By The Business Research Company

    Tanks Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/tanks-global-market-report

    Tank Wagons Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/tank-wagons-global-market-report

    Boiler Tank And Shipping Container Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • $12.84 Billion Forecast for Biologics Testing Market by 2029, Backed by Demand and Innovation

    $12.84 Billion Forecast for Biologics Testing Market by 2029, Backed by Demand and Innovation

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Projected Market Size and Growth Rates for the Biologics Testing Market From 2025 To 2029?

    There has been a fast-paced expansion in the size of the biologics testing market in the past few years. It is projected to increase from $5.92 billion in 2024 to $6.83 billion in 2025, with a compound annual growth rate (CAGR) of 15.4%. The overall growth in the past can be linked to the progression in biologics development, stiff regulatory norms, quality control in the process of bioprocessing, an increase in biopharmaceutical investments, and the expansion of the biomanufacturing capacity.

    The anticipated expansion of the biologics testing market is quite substantial, with a predicted growth to $12.84 billion by 2029, growing at a 17.1% compound annual growth rate. Various contributing factors for this expected growth include the advent of innovative therapies, the rising demand for third-party testing services, enlarging of biologics strategy, the internationalization of biopharmaceutical manufacturing, and an increased requirement for swift testing solutions. The period of prediction will also see numerous advancements, such as new analytical technologies, cell-based testing methods, next-generation sequencing, quality by design practices, AI integration, and quick product release procedures.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

    What Are the Core Growth Drivers Propelling the Biologics Testing Market Forward?

    The swift expansion of the pharmaceutical and biotech sectors is foreseen to bolster the biologics testing market’s growth. The predominant focus of the pharmaceutical industry is the creation and manufacturing of drugs for diverse diseases and health conditions. Conversely, the biotech sector is centered around utilizing technology in the sphere of biology and healthcare. Biologics testing encompasses impurity identification and quantification, stability assessment, and immune response evaluation to the drug. The growing pharmaceutical and biotech sectors have sparked progress in biologics testing technology, including the advent of novel analytical instruments and methods. This has paved the way for more precise and effective testing, decreasing the duration and expenses involved in introducing new biologics to the market. For example, Eurostat, a governing body based in Belgium, stated in July 2024 that pharmaceutical production in the EU rose from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, indicating considerable growth in the industry. Hence, the swiftly expanding pharmaceutical and biotech sectors are fueling the growth of the biologics testing market.

    What Segment Types Define the Biologics Testing Market Structure?

    The biologics testingmarket covered in this report is segmented –

    1) By Product: Reagents And Kits; Instruments; Other Products

    2) By Test Type: Endotoxin Test; Sterility Test; Mycoplasma Tests; Bioburden Tests; Residual Host-Cell Proteins And DNA Detection Tests; Virus Safety Test; Other Test Types

    3) By Application: Vaccine Development And Manufacturing; Monoclonal Antibodies Development And Manufacturing; Cellular And Gene Therapy Products Development And Manufacturing; Blood And Blood Products Development And Manufacturing; Other Applications

    Subsegments:

    1) By Reagents And Kits: ELISA Kits; PCR Kits; Cell Culture Reagents; Other Assay Kits

    2) By Instruments: Spectrophotometers; Chromatography Systems; Microplate Readers; Other Analytical Instruments

    3) By Other Products: Software; Consumables; Reference Standards

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Biologics Testing Market?

    North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Which Emerging Trends that Are Influencing theBiologics Testing Industry Evolution?

    One emerging trend in the biologics testing market is the evolution of product innovations. Firms in the field are embracing new inventive products to maintain their market share. As an example, Charles River Laboratories International, Inc., a non-clinical contract research organization based in the United States, introduced the Endosafe Nexus 200 in December 2022, broadening its endotoxin testing product line. This completely robotic, data integrity compliant instrument represents the next level in Charles River’s progression. The Nexus 200 utilizes Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and is adept at handling simple or intricate serial dilutions for water, in-process, and end product testing. Powered by Endosafe EndoScan-V version 6.1, the system allows for data export into a Laboratory Information Management System (LIMS) interface and provides improved traceability, security, and data management through an integrated touchscreen.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    What Is the Definition of the Biologics Testing Market?

    Biologics testing typically consists of a range of services aimed at evaluating the safety, efficacy, and quality of biological products.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10276

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Market Analysis on Biologics Testing Industry – Insights for Corporate Strategy and R&D

    Market Analysis on Biologics Testing Industry – Insights for Corporate Strategy and R&D

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Biologics Testing Market from 2024 to 2025?

    The market size of biologics testing has seen a swift expansion in the last few years. It is projected to surge from $5.92 billion in 2024 to $6.85 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 15.7%. The significant growth experienced in the past can be linked to the development in biologics, rigorous regulatory frameworks, emphasis on quality management in bioprocessing, rising investment in biopharmaceuticals, and the increase in the capacity for biomanufacturing.

    What Is the Projected Market Size of the Biologics Testing Market?

    The market size of biologics testing is predicted to experience fast-paced growth in the forthcoming years, with projections estimating it to reach “$12.91 billion by the year 2029, expanding at a compound annual growth rate (CAGR) of 17.2%. This growth during the forecast period can be credited to the development of novel therapies, the surging demand for contract testing services, broadening of biologics pipelines, globalization of biopharmaceutical manufacturing, and a rising demand for quick testing solutions. The forecast period is also anticipated to witness significant trends such as advanced analytical technologies, reliance on cell-based assays, next-generation sequencing (NGS), application of quality by design (QBD) principles, and integration of artificial intelligence (AI), along with rapid methods for product release.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

    Who are the Major Competitors in the Biologics Testing Market Outlook?

    Major companies operating in the biologics testing market include Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Celgene Corporation, Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Gilead Sciences Inc., Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, Johnson & Johnson Inc., QIAGEN N.V., GlaxoSmithKline plc, Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG, Novartis AG, Eli Lilly and Company, Pfizer Inc.

    What Is Fueling Growth in the Biologics Testing Market?

    The swift expansion of the biotechnology and pharmaceutical sectors is anticipated to drive the growth of the biologics testing market. The primary concern of the pharmaceutical industry includes the creation and development of medicines for a wide range of diseases and health problems. On the flip side, the biotechnology sector is centered around the exploitation of technology in the fields of biology and healthcare. Biologic testing involves the examination needed to discern and quantify contaminants, test stability, and assess the drug’s immunological response. The escalating growth of the biotechnology and pharmaceutical industries has triggered advancements in biologics testing technology, such as the introduction of innovative analytical tools and techniques. This has facilitated more precise and effective testing, decreasing the cost and duration needed to introduce new biologics to the market. For example, as per Eurostat, a Belgian regulatory organization, the production of pharmaceuticals in the EU witnessed a rise from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, showcasing substantial growth in the sector. Hence, the swift escalating pharmaceutical and biotechnological sectors drive the growth of the biologics testing market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

    Which Biologics Testing Market Segments Are Growing the Fastest?

    The biologics testing market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Other Products

    2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

    3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

    Subsegments:

    1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents, Other Assay Kits

    2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers, Other Analytical Instruments

    3) By Other Products: Software, Consumables, Reference Standards

    Which Industry Trends Are Shaping the Future of the Biologics Testing Market?

    The trend of product innovation is gaining traction in the biologics testing market. To maintain their market standing, companies in this field are introducing novel, innovative products. Most notable is the launch of the Endosafe Nexus 200 in December 2022 by Charles River Laboratories International, Inc., a non-clinical contract research organization based in the US. This instrument is fully robotized, data integrity compliant, and serves as an advancement in Charles River’s line of products. The Nexus 200 employs Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and has the capacity to handle straightforward or intricate serial dilutions for water, in-process, and final product assessments. The system functions on Endosafe EndoScan-V version 6.1, allowing data to be transferred to a Laboratory Information Management System (LIMS) interface providing increased traceability, security, and data management via an integrated touchscreen.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Which Countries Are Leading the Biologics Testing Market?

    North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10276

    This Report Delivers Insight On:

    1. How big is the biologics testing market, and how is it changing globally?

    2. Who are the major companies in the biologics testing market, and how are they performing?

    3. What are the key opportunities and risks in the biologics testing market right now?

    4. Which products or customer segments are growing the most in the biologics testing market?

    5. What factors are helping or slowing down the growth of the biologics testing market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biologics Testing Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    Biologics Testing Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    Discover trends, market shifts, and competitive outlooks for the biologics testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    What Is the Current and Projected Market Size of the Biologics Testing Market Through 2034?

    In recent times, there has been a swift expansion in the biologics testing market size. The market is projected to surge from $5.92 billion in 2024 to $6.85 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.7%. Factors driving this escalation during the historical phase include growth in biologics development, rigorous regulatory standards, effective quality control in bioprocessing, an increase in biopharmaceutical investments, and an expansion of biomanufacturing capacity.

    In the coming years, the biologics testing market is poised for swift expansion, and it is projected to reach a valuation of “$12.91 billion by 2029, growing at a compound annual growth rate (CAGR) of 17.2%. The accelerated growth during the forecast period can be credited to the advent of cutting-edge therapies, a rising need for contract testing services, enlargement of biologics pipelines, the worldwide expansion of biopharmaceutical manufacturing, and an increased demand for expedited testing solutions. Key trends during this period will consist of advanced analytical technologies, cell-based assays, next-generation sequencing (NGS), principles of quality by design (QBD), the incorporation of artificial intelligence (AI), and more rapid methods for product launch.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

    What Are the Major Market Drivers Behind the Rising Adoption of Biologics Testing Market?

    The swift expansion of both the pharmaceutical and biotechnology sectors is anticipated to fuel the growth of the biologics testing market. The key focus of the pharmaceutical industry is on the development and production of drugs for a variety of diseases and health conditions, whereas the biotechnology industry concentrates on implementing technology in biology and healthcare. Biologics testing involves procedures to confirm and measure impurities, check stability, and inspect the immunity response to the drug. The expansion of the pharmaceutical and biotechnology sectors has subsequently promoted advancements in biologics testing technology, like the creation of novel analytical instruments and methods. This progress has facilitated more precise and efficient testing, which helps in reducing the length and cost of introducing new biologics into the market. For example, in July 2024, Eurostat, a governing body based in Belgium, reported that EU pharmaceutical production had grown from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, indicating substantial growth in the industry. Hence, the fast-paced growth of the pharmaceutical and biotechnology industries is steering the growth of the biologics testing market.

    Which Key Market Segments Comprise the Biologics Testing Market and Drive Its Revenue Growth?

    The biologics testing market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Other Products

    2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

    3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

    Subsegments:

    1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents, Other Assay Kits

    2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers, Other Analytical Instruments

    3) By Other Products: Software, Consumables, Reference Standards

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

    Which Areas Are Leading Regions in the Biologics Testing Market Expansion Across the Globe?

    North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Are the Strategic Trends Steering theBiologics Testing Market Direction?

    Advancements in product technology is becoming a significant trend in the biologics testing market, as companies introduce innovative products to maintain their market stance. For example, in December 2022, Charles River Laboratories International, Inc., a leading non-clinical contract research firm from the United States, introduced a new device called the Endosafe Nexus 200 to its expansive endotoxin testing collection. The Nexus 200, a fully automatic, data-integrity compliant equipment, is a cutting-edge development for Charles River. The device utilizes Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and is capable of handling simple or complex serial dilutions for the testing of water, in-process, and final products. Operating on the Endosafe EndoScan-V Version 6.1, the system can export data to a Laboratory Information Management System (LIMS) interface, providing increased traceability, security, and data management through an integrated touchscreen.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    How Is the Biologics Testing Market Conceptually Defined?

    Biologics testing typically consists of a range of services aimed at evaluating the safety, efficacy, and quality of biological products.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10276

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model